Tokai Pharma (TKAI) Reports Q2 Loss Per Share of $0.40
Tweet
Share
E-mailGet Alerts TKAI Hot Sheet
Join SI Premium – FREE
Tokai Pharma (NASDAQ: TKAI) reported Q2 EPS of ($0.40), versus ($11.68) reported last year.
For earnings history and earnings-related data on Tokai Pharma (TKAI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Broadcom credit risk measures rise amid AI financing deals
- UBS Upgrades Geely Automotive Holdings Ltd. (175:HK) (GELYF) to Buy
- TORM appoints Jann Brown to its board of directors
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
